“We remain intently focused on the critical mission of working with our partners and customers to expand the use of our VioSafe™ LEDs to protect public health and save lives by reducing the risk of infections,” Vital Vio CEO Colleen Costello said.
TROY, N.Y. (PRWEB) December 06, 2017
Vital Vio, Inc., the health care solutions company that has reinvented disinfection with its VioSafe™ LEDs, issued the following statement in response to recent claims by Kenall Manufacturing:
The recent suggestion by Kenall Manufacturing - made in a November 28, 2017 press release - that it is “the exclusive licensee for markets in North America” for the use of visible light to safely disinfect environments, is not supported by facts.
As a result of Vital Vio’s firm and ongoing commitment to research and discovery; Vital Vio has been awarded three U.S. Patents for our innovative White Light Disinfection™ technologies, platforms, and products, with numerous additional patents pending. Vital Vio is the sole owner of all of its intellectual property portfolio. As is common in a competitive business market, there are multiple patent owners and not one exclusive operator in the visible light disinfection market.
Vital Vio’s research-tested proprietary technology has been licensed to industry leaders that manufacture lighting solutions in health care, athletics, hospitality, education, emergency vehicle, and other market sectors. Many of our partners are poised to bring new products to market that integrate our White Light Disinfection™ technology, thereby providing customers the opportunity to install lights that multi-task to kill germs while safely illuminating indoor spaces.
The fact is, Vital Vio and its other licensing partners operate under Vital Vio’s next generation and most commercially relevant proprietary technology, which is distinct and unrelated to the patent referenced in Kenall’s recently filed lawsuits. Kenall is fully aware of this distinction having previously dismissed a lawsuit between itself and Vital Vio over the same patent cited in the recently filed complaint. Vital Vio is not named in the recent Kenall complaint.
“We are examining all available options and intend to prevent any further frivolous attempts to interfere with the ongoing mission of our company and the business operations of our partners,” CEO and Co-Founder Colleen Costello said.
Vital Vio is a leader in clinical research demonstrating the germ-killing power and potential of White Light Disinfection™ and related innovations in continuous disinfection as a result of its multi-year investment in R&D. “We remain intently focused on the critical mission of working with our partners and customers to expand the use of our VioSafe™ LEDs to protect public health and save lives by reducing the risk of infections,” Costello said.
About Vital Vio
Vital Vio is a health care solutions company that has reinvented disinfection, providing facilities managers and home-owners new tools to continuously kill germs indoors with the flip of a light switch. The company’s VioSafe™ White Light Disinfection™ technology is suitable for continuous human exposure. Used in combination with traditional intermittent cleaning in hospitals, homes, public spaces, and workplaces, Vital Vio’s technology multi-tasks to safely, effectively, and continuously kill bacteria and other harmful organisms on indoor surfaces, while also illuminating the room.
Contact: Media@vitalvio.com | Information: http://www.vitalvio.com